M Kłos1, M Pomorska-Wesołowska2, D Romaniszyn3, J Wójkowska-Mach3, A Chmielarczyk3. 1. Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland. 2. Department of Microbiology, Analytical and Microbiological Laboratory, KORLAB, Ruda Slaska, Poland. 3. Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Abstract
BACKGROUND AND AIMS: Bloodstream infections (BSIs) are one of the most frequently observed hospital-acquired infections (HAIs). We sought to describe the epidemiology and drug resistance secondary Enterobacterales BSIs in surgical patients and check for any correlation with the type of hospital ward. MATERIALS AND METHODS: This multicenter (13 hospitals in southern Poland) laboratory-based retrospective study evaluated adults diagnosed with BSI secondary to surgical site infection (SSI) hospitalized in 2015-2018; 121 Enterobacterales strains were collected. The drug resistance was tested according to the EUCAST recommendations. Tests confirming the presence of extended-spectrum β-lactamases (ESBLs) and bla resistance genes were carried out. The occurrence of possible clonal epidemics among K. pneumoniae strains was examined. RESULTS: The prevalence of Enterobacterales in secondary BSI was 12.1%; the most common strains were E. coli (n = 74, 61.2%) and Klebsiella spp. (n = 33, 27.2%). High resistance involved ampicillin and ampicillin/sulbactam (92, 8-100%), fluoroquinolones (48-73%), and most cephalosporins (29-50%). Carbapenems were the antimicrobials with the susceptibility at 98%. The prevalence of ESBL strains was 37.2% (n = 45). All the ESBL strains had bla CTX-M gene, 26.7% had the bla SHV gene, and 24.4% had bla TEM gene. The diversity of Klebsiella strains was relatively high. Only 4 strains belonged to one clone. CONCLUSIONS: What is particularly worrying is the high prevalence of Enterobacterales in BSI, as well as the high resistance to antimicrobial agents often used in the empirical therapy. To improve the effectiveness of empirical treatment in surgical departments, we need to know the epidemiology of both surgical site infection and BSI, secondary to SSI. We were surprised to note high heterogeneity among K. pneumoniae strains, which was different from our previous experience.
BACKGROUND AND AIMS: Bloodstream infections (BSIs) are one of the most frequently observed hospital-acquired infections (HAIs). We sought to describe the epidemiology and drug resistance secondary Enterobacterales BSIs in surgical patients and check for any correlation with the type of hospital ward. MATERIALS AND METHODS: This multicenter (13 hospitals in southern Poland) laboratory-based retrospective study evaluated adults diagnosed with BSI secondary to surgical site infection (SSI) hospitalized in 2015-2018; 121 Enterobacterales strains were collected. The drug resistance was tested according to the EUCAST recommendations. Tests confirming the presence of extended-spectrum β-lactamases (ESBLs) and bla resistance genes were carried out. The occurrence of possible clonal epidemics among K. pneumoniae strains was examined. RESULTS: The prevalence of Enterobacterales in secondary BSI was 12.1%; the most common strains were E. coli (n = 74, 61.2%) and Klebsiella spp. (n = 33, 27.2%). High resistance involved ampicillin and ampicillin/sulbactam (92, 8-100%), fluoroquinolones (48-73%), and most cephalosporins (29-50%). Carbapenems were the antimicrobials with the susceptibility at 98%. The prevalence of ESBL strains was 37.2% (n = 45). All the ESBL strains had bla CTX-M gene, 26.7% had the bla SHV gene, and 24.4% had bla TEM gene. The diversity of Klebsiella strains was relatively high. Only 4 strains belonged to one clone. CONCLUSIONS: What is particularly worrying is the high prevalence of Enterobacterales in BSI, as well as the high resistance to antimicrobial agents often used in the empirical therapy. To improve the effectiveness of empirical treatment in surgical departments, we need to know the epidemiology of both surgical site infection and BSI, secondary to SSI. We were surprised to note high heterogeneity among K. pneumoniae strains, which was different from our previous experience.
Authors: Mariana Castanheira; Janet C Mills; Sarah E Costello; Ronald N Jones; Helio S Sader Journal: Antimicrob Agents Chemother Date: 2015-04-06 Impact factor: 5.191
Authors: Thomas M Hooton; Suzanne F Bradley; Diana D Cardenas; Richard Colgan; Suzanne E Geerlings; James C Rice; Sanjay Saint; Anthony J Schaeffer; Paul A Tambayh; Peter Tenke; Lindsay E Nicolle Journal: Clin Infect Dis Date: 2010-03-01 Impact factor: 9.079
Authors: Oded Scheuerman; Vered Schechner; Yehuda Carmeli; Belen Gutiérrez-Gutiérrez; Esther Calbo; Benito Almirante; Pier-Luigy Viale; Antonio Oliver; Patricia Ruiz-Garbajosa; Oriol Gasch; Monica Gozalo; Johann Pitout; Murat Akova; Carmen Peña; Jose Molina; Alicia Hernández-Torres; Mario Venditti; Nuria Prim; Julia Origüen; German Bou; Evelina Tacconelli; Maria Tumbarello; Axel Hamprecht; Ilias Karaiskos; Cristina de la Calle; Federico Pérez; Mitchell J Schwaber; Joaquin Bermejo; Warren Lowman; Po-Ren Hsueh; Carolina Navarro-San Francisco; Robert A Bonomo; David L Paterson; Alvaro Pascual; Jesus Rodríguez-Baño Journal: Infect Control Hosp Epidemiol Date: 2018-04-05 Impact factor: 3.254
Authors: Christian Sakellariou; Stephan Gürntke; Ivo Steinmetz; Christian Kohler; Yvonne Pfeifer; Petra Gastmeier; Frank Schwab; Axel Kola; Maria Deja; Rasmus Leistner Journal: PLoS One Date: 2016-07-21 Impact factor: 3.240
Authors: Vincent Jarlier; Liselotte Diaz Högberg; Ole E Heuer; José Campos; Tim Eckmanns; Christian G Giske; Hajo Grundmann; Alan P Johnson; Gunnar Kahlmeter; Jos Monen; Annalisa Pantosti; Gian Maria Rossolini; Nienke van de Sande-Bruinsma; Alkiviadis Vatopoulos; Dorota Żabicka; Helena Žemličková; Dominique L Monnet; Gunnar Skov Simonsen Journal: Euro Surveill Date: 2019-08